These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25359342)

  • 1. Variability of within-breath reactance in COPD patients and its association with dyspnoea.
    Aarli BB; Calverley PM; Jensen RL; Eagan TM; Bakke PS; Hardie JA
    Eur Respir J; 2015 Mar; 45(3):625-34. PubMed ID: 25359342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of expiratory flow limitation in COPD using the forced oscillation technique.
    Dellacà RL; Santus P; Aliverti A; Stevenson N; Centanni S; Macklem PT; Pedotti A; Calverley PM
    Eur Respir J; 2004 Feb; 23(2):232-40. PubMed ID: 14979497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of the forced oscillation technique for titration of pressure support levels in chronic obstructive pulmonary disease patients during nasal noninvasive positive pressure ventilation].
    Wang H; Chen RC; He S; Luo Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jan; 32(1):21-6. PubMed ID: 19484957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.
    Paredi P; Goldman M; Alamen A; Ausin P; Usmani OS; Pride NB; Barnes PJ
    Thorax; 2010 Mar; 65(3):263-7. PubMed ID: 20335298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
    Aarli BB; Calverley PM; Jensen RL; Dellacà R; Eagan TM; Bakke PS; Hardie JA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2179-2188. PubMed ID: 28794622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing respiratory rate on airway resistance and reactance in COPD patients.
    Nakagawa M; Hattori N; Haruta Y; Sugiyama A; Iwamoto H; Ishikawa N; Fujitaka K; Murai H; Tanaka J; Kohno N
    Respirology; 2015 Jan; 20(1):87-94. PubMed ID: 25251948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway distensibility and volume recruitment with lung inflation in COPD.
    Baldi S; Dellacà R; Govoni L; Torchio R; Aliverti A; Pompilio P; Corda L; Tantucci C; Gulotta C; Brusasco V; Pellegrino R
    J Appl Physiol (1985); 2010 Oct; 109(4):1019-26. PubMed ID: 20651219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the forced oscillation technique with negative expiratory pressure in COPD.
    Akita T; Shirai T; Mori K; Shimoda Y; Suzuki T; Hayashi I; Noguchi R; Mochizuki E; Sakurai S; Saigusa M; Akamatsu T; Yamamoto A; Shishido Y; Morita S; Asada K; Suda T
    Respir Physiol Neurobiol; 2016 Jan; 220():62-8. PubMed ID: 26369446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expiratory flow limitation detected by negative expiratory pressure in patients with chronic obstructive pulmonary disease].
    Chen AH; Chen RC; Li JM; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):236-9. PubMed ID: 16750038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD.
    Dellacà RL; Pompilio PP; Walker PP; Duffy N; Pedotti A; Calverley PM
    Eur Respir J; 2009 Jun; 33(6):1329-37. PubMed ID: 19164347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
    Jarenbäck L; Ankerst J; Bjermer L; Tufvesson E
    Respir Med; 2016 Jan; 110():28-33. PubMed ID: 26607879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of inspiratory and expiratory reactance in interstitial lung disease.
    Sugiyama A; Hattori N; Haruta Y; Nakamura I; Nakagawa M; Miyamoto S; Onari Y; Iwamoto H; Ishikawa N; Fujitaka K; Murai H; Kohno N
    Respir Med; 2013 Jun; 107(6):875-82. PubMed ID: 23582576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between impulse oscillometry, spirometry and dyspnoea in COPD.
    Anderson WJ; Lipworth BJ
    J R Coll Physicians Edinb; 2012 Jun; 42(2):111-5. PubMed ID: 22693693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis?
    Holland AE; Denehy L; Wilson JW
    Eur Respir J; 2006 Jul; 28(1):96-101. PubMed ID: 16540499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly.
    Aarli BB; Eagan TM; Ellingsen I; Bakke PS; Hardie JA
    Clin Respir J; 2013 Jul; 7(3):245-52. PubMed ID: 22822726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of COPD patients with tidal expiratory flow limitation.
    Dean J; Kolsum U; Hitchen P; Gupta V; Singh D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1503-1506. PubMed ID: 28579768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between expiratory muscle dysfunction and dynamic hyperinflation in advanced chronic obstructive pulmonary disease].
    Mota S; Güell R; Barreiro E; Casan P; Gea J; Sanchis J
    Arch Bronconeumol; 2009 Oct; 45(10):487-95. PubMed ID: 19631439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.